Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
---|
02/26/2004 | US20040038406 Nanoparticle delivery systems and methods of use thereof |
02/26/2004 | US20040038400 Methods for regulating gene expression using light |
02/26/2004 | US20040038374 Method for accessing microbial diversity |
02/26/2004 | US20040038357 Producing a fagopyritol, an insulin mediator, an insulin mediator analogue, an insulin mediator homologue, or an insulin mediator inhibitor |
02/26/2004 | US20040038348 Synthetic heparin-binding growth factor analogs |
02/26/2004 | US20040038344 Compositions and methods of the invention provide isolated N-terminally truncated alpha6 integrin polypeptides, also called "alpha6 integrin variants," and methods of making the polypeptides |
02/26/2004 | US20040038343 Used in the diagnosis, treatment, and prevention of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, and metabolic disorders, and viral infections |
02/26/2004 | US20040038338 Influence of LRP cytoplasmic domain on Abeta production |
02/26/2004 | US20040038337 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
02/26/2004 | US20040038336 Identification and isolation of novel DNA and to the recombinant production of novel polypeptides |
02/26/2004 | US20040038335 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
02/26/2004 | US20040038316 Cell separation device and methods for use |
02/26/2004 | US20040038303 Comprises use of small particle with appropriate hydrophilic-lipophilic-balance value to deliver anticarcinogenic agents to cells and/or tissues; drug screening |
02/26/2004 | US20040038290 Comprises nucleotide sequences coding heat resistant polymerase for use as DNA replication/amplification tool in genetic engineering |
02/26/2004 | US20040038289 Nucleic acid encoding bacillus stearothermophilus delta polymerase subunit |
02/26/2004 | US20040038274 Gapped 2' modified oligonucleotides |
02/26/2004 | US20040038273 Bifunctional tRNA for in vitro selection |
02/26/2004 | US20040038272 Microsatellite markers |
02/26/2004 | US20040038268 Support bound probes and methods of analysis using the same |
02/26/2004 | US20040038267 Comprises polypeptide associated with signal transduction for diagnosis, treatment and prevention of cell proliferative, autoimmune/inflammatory, nervous system, gastrointestinal, reproductive and developmental disorders |
02/26/2004 | US20040038255 Silver-gold shelled composite oligonucleotide conjugate for detecting target nucleic acids, peptides and proteins; colorimetric based DNA detection |
02/26/2004 | US20040038242 Novel secreted proteins and their uses |
02/26/2004 | US20040038232 Compositions and methods for modulating tumor specific expression |
02/26/2004 | US20040038222 Comprises nucleotide sequences coding chimeric kinesin like motor protein (KIFLC) which confers resistance to lethal toxin (LETX) associated with bacillus infection |
02/26/2004 | US20040038211 Primer composition and method of using the same in the detection of shigella sonnei |
02/26/2004 | US20040038203 Comprises nucleotide sequences coding yaba monkey tumor viral protein for treatment and prevention of autoimmune diseases |
02/26/2004 | US20040038196 Immunoblobulin directed against smallpox inhibitor of complement enzyme (SPICE) for preventing and treating poxviral infections |
02/26/2004 | US20040037846 Chlamydia pmp proteins, gene sequences and uses thereof |
02/26/2004 | US20040037805 DNA (RNA) encoding such chemokine polypeptides and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such chemokine polypeptides for the treatment of |
02/26/2004 | US20040035690 For parallel synthesis and assay of biopolymers using light-directed generation of photo-generated reagents on microarray biochips |
02/26/2004 | DE10237517A1 Removing biomolecules from liquid media, useful for purification, product recovery or preparation of vectors, comprises retention on hydrotalcite of controlled porosity |
02/26/2004 | CA2535760A1 Apicomplexan pathways, inhibitiors, and drug delivery |
02/26/2004 | CA2497304A1 Bmp-2 estrogen responsive element and methods of using the same |
02/26/2004 | CA2495664A1 Novel variant hyprocrea jecorina cbh1 cellulases |
02/26/2004 | CA2493753A1 Immunostimulatory nucleic acids |
02/25/2004 | EP1390710A2 Amplification and detection of $i(mycoplasma pneumoniae) |
02/25/2004 | EP1390547A1 Antisense modulation of interleukin 12 p35 subunit expression |
02/25/2004 | EP1390545A1 Biological sample processing methods and compositions that include surfactants |
02/25/2004 | EP1390541A2 Method for detecting gram-positive bacteria |
02/25/2004 | EP1390508A2 A retinoic acid metabolizing cytochrome p450 |
02/25/2004 | EP1390493A1 Antisense oligonucleotide against human acetylcholinesterase (ache) and uses thereof |
02/25/2004 | EP1390486A2 Isolated human aminoacylase, nucleic acid molecules encoding human aminoacylase, and uses thereof |
02/25/2004 | EP1390472A2 Nucleic acid treatment of diseases or conditions related to levels of ras, her2 and hiv |
02/25/2004 | EP1390408A1 A molecular marker |
02/25/2004 | EP1390382A1 Elucidation of gene function |
02/25/2004 | EP1390075A2 Chemotherapeutic induction of egr-1 promoter activity |
02/25/2004 | EP1017704B1 Use of a pentopyranosyl nucleoside containing conjugate for producing an array |
02/25/2004 | EP0751957B1 Peptide fragments of microbial stress proteins and pharmaceutical composition made thereof for the treatment and prevention of inflammatory diseases |
02/25/2004 | CN1478148A Novel transcriptional factor enhancing resistance of plants to osmotic stress |
02/25/2004 | CN1477125A A polypeptide-human amelification protein 23 and polynucleotide for coding said polypeptide |
02/25/2004 | CN1477124A A polypeptide-zinc finger protein 42 and polynucleotide for coding said polypeptide |
02/25/2004 | CN1477123A A polypeptide-transcription factor 43 and polynucleotide coding said polypeptide |
02/25/2004 | CN1477122A A polypeptide-human blood vessel epithelial calcium adhesion protein 54 and polynuceotide for coding said polypeptide |
02/25/2004 | CN1477121A A polypeptide-human ankyrin 27 and polynucleotide coding said polypeptide |
02/25/2004 | CN1477120A A polypeptide-human tissue anion transport polypeptide 41 and polynucleotide coding said polypeptide |
02/25/2004 | CN1477119A Novel Human cysteine proteinase inhibitor sample molecule, its coding sequence and application |
02/25/2004 | CN1477118A Novel DnaJ/Hsp40 molecule DC-DJIII, its coding sequence and application |
02/25/2004 | CN1477117A Novel human phosphotidylethanolamine binding protein, its coding sequence and application |
02/25/2004 | CN1477116A Novel human secretion-related membrane protion, its coding sequence and its application |
02/25/2004 | CN1477115A Novel human cyclin, its coding sequence and application |
02/25/2004 | CN1477114A Immunoglobulin sample receptor originated from human dendritic cell, its coding sequence and application |
02/25/2004 | CN1139385C Method and composition for lipidization of hydrophilic molecules |
02/24/2004 | US6696555 3'-Desoxypentopyranosyl nucleic acid, its production and its use |
02/24/2004 | US6696275 Generating preferential polypeptide; obtain nucleotide sequences, mutate, express nucleotide sequences, separate and recover polypeptide |
02/24/2004 | US6696255 Nucleic acid hairpin probes and uses thereof |
02/24/2004 | US6696252 High-affinity oligonucleotide ligands to vascular endothelial growth factor (VEGF) |
02/24/2004 | US6696242 Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
02/24/2004 | US6696061 Binds human major histocompatibility complex (mhc) class ii allotype |
02/24/2004 | CA2250014C Asymmetric benzoxanthene dyes |
02/19/2004 | WO2004015395A2 Method for identifying mhc-presented peptide epitopes for t cells |
02/19/2004 | WO2004015142A1 Uncoupling of dna propagation and expression of protein for phage display |
02/19/2004 | WO2004015126A2 Antisense modulation of edg1 expression |
02/19/2004 | WO2004015125A1 Process for preparing peptides with anti-hypertensive properties |
02/19/2004 | WO2004015109A1 Human acid sensing ion channel 2b (hasic2b), process for producing the same, and its use |
02/19/2004 | WO2004015107A2 Further novel forms of interfering rna molecules |
02/19/2004 | WO2004015079A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
02/19/2004 | WO2004014946A1 A novel homo protein with cancer suppressing function and its coding sequence |
02/19/2004 | WO2004014933A1 Compositions for rna interference and methods of use thereof |
02/19/2004 | WO2004014312A2 Small-mer compositions and methods of use |
02/19/2004 | WO2004014311A2 Nogo receptor antagonists |
02/19/2004 | WO2004014299A2 Antisense modulation of resistin expression |
02/19/2004 | WO2004014131A1 KNOCKIN NONHUMAN ANIMAL AND TISSUE-SPECIFIC MnSOD-KNOCKOUT NONHUMAN ANIMAL |
02/19/2004 | WO2004001016A3 Methods for detection of genetic alterations associated with cancer |
02/19/2004 | WO2003085124A8 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
02/19/2004 | WO2003070904A3 Human rnase iii and compositions and uses thereof |
02/19/2004 | WO2003042364A3 Identifying and controlling the growth of estrogen-responsive cells |
02/19/2004 | WO2002088184A9 A molecular marker |
02/19/2004 | WO2002070750A3 Method of determining dihydropyrimidine dehydrogenase gene expression |
02/19/2004 | WO2002032920A3 Modified nucleosides for treatment of viral infections and abnormal cellular proliferation |
02/19/2004 | US20040034888 Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement |
02/19/2004 | US20040034884 Trichothecene-resistant transgenic plants |
02/19/2004 | US20040034878 Using transgenic hypercellular nonhuman organisms as cell proliferating gene therapeutic tools |
02/19/2004 | US20040034209 Using genetic vaccine to treat and prevent infection by lymphadenopathy associated virus; viricides |
02/19/2004 | US20040034208 Comprises nucleotide sequences coding regulatory proteins such as cytokines and interferons for diagnosis and treatment of neurodegenerative, pancreatic and viral diseases |
02/19/2004 | US20040034199 Human pellino polypeptides |
02/19/2004 | US20040034194 Comprises thera.peutic polypeptide for treating and preventing cancer, obesity, diabetes, hyper/hypotension, eating, nervous system and sexual disorders |
02/19/2004 | US20040033980 Method of down-regulating gene expression |
02/19/2004 | US20040033978 Antisense oligonucleotides complementary to and that hybridize with RNA, used for gene expression inhibition, prophylaxis and medical diagnosis |
02/19/2004 | US20040033977 Oligonucleotide modulation of cell adhesion |
02/19/2004 | US20040033942 Transriotion factors |